Common pharmacological inducers of P-glycoprotein include carbamazepine, dexamethasone, doxorubicin, nefazodone, phenobarbital, phenytoin, prazosin, rifampicin, St. John’s wort, tenofovir, tipranavir, trazodone, and vinblastine.
Which transporter in Git is responsible drug efflux?
P-glycoprotein
P-glycoprotein is located at the membrane of enterocytes that facilitates efflux of drug compounds from inside epithelial cells back to the intestinal lumen to limit the transport of drug molecules into the systemic circulation or prevent drug absorption, causing oral bioavailability and concentration of the drug to be …
How does P-glycoprotein work in intestine?
In the GI tract, P-gp is located on the apical surface of the mature epithelial cells and acts as a pump that transports drugs back into the GI lumen as they are absorbed across the intestinal mucosa.
What do P-glycoprotein inducers do?
Drug absorption Like the enzymes involved in drug metabolism, substrates of P-glycoprotein can potentially act as inhibitors or inducers of its function. Inhibition of P-glycoprotein can result in increased bioavailability of the susceptible drug. Induction of P-glycoprotein reduces the bioavailability.
What is P-glycoprotein transporter?
Pgp (P-glycoprotein) (ABCB1) is an ATP-powered efflux pump which can transport hundreds of structurally unrelated hydrophobic amphipathic compounds, including therapeutic drugs, peptides and lipid-like compounds. It forms a major component of the blood-brain barrier and restricts the uptake of drugs from the intestine.
What are efflux transporters?
Efflux pumps are proteinaceous transporters localized in the cytoplasmic membrane of all kinds of cells. They are active transporters, meaning that they require a source of chemical energy to perform their function.
How do efflux transporters work?
Efflux transporters prevent fluorescent dyes from entering the cytoplasm and provide a simple means of assaying activity.
What happens when P-glycoprotein is induced?
In the gut, P-glycoprotein pumps drugs back into the lumen, decreasing their absorption. Drugs which induce P-glycoprotein, such as rifampicin, can reduce the bioavailability of some other drugs. Inhibitors of P-glycoprotein, such as verapamil, increase the bioavailability of susceptible drugs.
What is expression of P-glycoprotein?
P-glycoprotein (Pgp) is the first detected and the best characterized of ABC drug efflux transporters. Apart from tumor cells, its constitutive expression has been reported in a variety of other tissues, such as the intestine, brain, liver, placenta, kidney, and others.
What does the P-glycoprotein do?
P-glycoprotein, the most extensively studied ATP-binding cassette (ABC) transporter, functions as a biological barrier by extruding toxins and xenobiotics out of cells. In vitro and in vivo studies have demonstrated that P-glycoprotein plays a significant role in drug absorption and disposition.
How does efflux work?
Drug efflux is a key mechanism of resistance in Gram-negative bacteria. These systems pump solutes out of the cell. Efflux pumps allow the microorganisms to regulate their internal environment by removing toxic substances, including antimicrobial agents, metabolites and quorum sensing signal molecules.
What does P-glycoprotein do?
What drugs are substrates of the P-gp efflux pump?
Examples of drugs that are substrates of P-gp efflux pump include: Apixaban, colchicine, cyclosporine, dabigatran, digoxin, edoxaban, rivaroxaban, and tacrolimus. The degree of effect on P-gp substrate serum concentration may be altered by dose and timing of orally administered P-gp inhibitor or inducer.
What is the function of the efflux pump ATP-GP?
P-gp is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs.
What drugs are inducers of P-glycoprotein?
Common pharmacological inducers of P-glycoprotein include carbamazepine, dexamethasone, doxorubicin, nefazodone, phenobarbital, phenytoin, prazosin, rifampicin, St. John’s wort, tenofovir, tipranavir, trazodone, and vinblastine.
What is the difference between inhibitors and inducers of P-gp?
Inhibitors of the P-gp drug efflux pump (also known as P-gp multidrug resistance transporter) listed above may increase serum concentrations of drugs that are substrates of P-gp, whereas inducers of P-gp drug efflux may decrease serum concentrations of substrates of P-gp.
